HemaSphere (Aug 2023)
P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE-EXPANSION PHASE OF THE CC-92480-MM-001 TRIAL
- Nizar J Bahlis,
- Suzanne Trudel,
- Hang Quach,
- Rakesh Popat,
- Sagar Lonial,
- Robert Z Orlowski,
- Kihyun Kim,
- Maria-Victoria Mateos,
- Charlotte Pawlyn,
- Karthik Ramasamy,
- Joaquín Martinez-Lopez,
- Ignacio Casas-Avilés,
- Alessia Spirli,
- Jing Gong,
- Michael Amatangelo,
- Jessica Katz,
- Paulo Maciag,
- Teresa Peluso,
- Paul Richardson
Affiliations
- Nizar J Bahlis
- 1 Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada
- Suzanne Trudel
- 2 Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
- Hang Quach
- 3 St. Vincent’s Hospital Melbourne, University of Melbourne, Melbourne, VIC, Australia
- Rakesh Popat
- 4 NIHR UCLH Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, United Kingdom
- Sagar Lonial
- 5 Winship Cancer Institute, Emory University, Atlanta, GA, United States
- Robert Z Orlowski
- 6 Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
- Kihyun Kim
- 7 Sungkyunkwan University, Samsung Medical Center, Seoul, Korea, Rep. of South
- Maria-Victoria Mateos
- 8 University Hospital of Salamanca/IBSAL, Salamanca, Spain
- Charlotte Pawlyn
- 9 The Royal Marsden NHS Foundation, London, United Kingdom
- Karthik Ramasamy
- 11 Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
- Joaquín Martinez-Lopez
- 12 Department of Hematology, Hospital 12 de Octubre, Complutense University, H12O-CNIO Clinical Research Unit, CIBERONC, Madrid, Spain
- Ignacio Casas-Avilés
- 13 Hospital San Pedro de Alcántara, Cáceres, Spain
- Alessia Spirli
- 14 Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland
- Jing Gong
- 15 Bristol Myers Squibb, Princeton, NJ, United States
- Michael Amatangelo
- 15 Bristol Myers Squibb, Princeton, NJ, United States
- Jessica Katz
- 15 Bristol Myers Squibb, Princeton, NJ, United States
- Paulo Maciag
- 15 Bristol Myers Squibb, Princeton, NJ, United States
- Teresa Peluso
- 14 Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland
- Paul Richardson
- 16 Dana-Farber Cancer Institute, Boston, MA, United States
- DOI
- https://doi.org/10.1097/01.HS9.0000970376.71405.63
- Journal volume & issue
-
Vol. 7
p. e7140563
Abstract
No abstracts available.